Evidence map›Paper›PMID 32043300›Full record

ArticleEMBO reports2020

Optogenetic control of mitochondrial protonmotive force to impact cellular stress resistance.

Brandon J Berry, Adam J Trewin, Alexander S Milliken, Aksana Baldzizhar, Andrea M Amitrano, Yunki Lim, Minsoo Kim, Andrew P Wojtovich

Open access · greenAbstract read
In one paragraph

Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Optogenetic engineering for precision cancer immunotherapy.Trends in pharmacological sciences · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. From mitochondria to cells to humans: Targeting bioenergetics in aging and disease.The international journal of biochemistry & cell biology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Optogenetic Studies of Mitochondria.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Brandon J BerryDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-2206-7615
Adam J TrewinDepartment of Anesthesiology and Perioperative Medicine, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0001-7322-4054
Alexander S MillikenDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY, USA.
Aksana BaldzizharDepartment of Anesthesiology and Perioperative Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Andrea M AmitranoDepartment of Pathology, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-1101-872X
Yunki LimNephrology Division, Department of Medicine, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.
Minsoo KimDepartment of Pathology, University of Rochester Medical Center, Rochester, NY, USA.
Andrew P WojtovichDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-7725-5349
University of Rochester Medical Center · US

Funding

The T32 Predoctoral Training Program in Immunology (PTPI)T32AI007285 · NIAID · UNIVERSITY OF ROCHESTER · PI Scott Andrew Gerber, JACQUES Robert · 1986 to 2026
$7.6M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Training in Cellular, Biochemical and Molecular SciencesT32GM068411 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 2005 to 2019
$3.9M
Mitochondrial ROS Microdomains and Neuronal IschemiaR01NS092558 · NINDS · UNIVERSITY OF ROCHESTER · PI WOJTOVICH, ANDREW PHILLIP · 2015 to 2025
$3.7M
Mitochondrial Energy Sensing and Neuronal IschemiaR01NS115906 · NINDS · UNIVERSITY OF ROCHESTER · PI Andrew P Wojtovich · 2020 to 2026
$3.0M
Optical control of T cell metabolismR21CA242843 · NCI · UNIVERSITY OF ROCHESTER · PI KIM, MINSOO, WOJTOVICH, ANDREW PHILLIP · 2020 to 2021
$396k
NCI NIH HHS R21 CA242843NIAID NIH HHS T32 AI007285NIGMS NIH HHS T32 GM068411NIH HHS P40 OD010440NINDS NIH HHS R01 NS092558NINDS NIH HHS R01 NS115906
6 · The paper itself

Abstract

Mitochondrial respiration generates an electrochemical proton gradient across the mitochondrial inner membrane called protonmotive force (PMF) to drive diverse functions and synthesize ATP. Current techniques to manipulate the PMF are limited to its dissipation; yet, there is no precise and reversible method to increase the PMF. To address this issue, we aimed to use an optogenetic approach and engineered a mitochondria-targeted light-activated proton pump that we name mitochondria-ON (mtON) to selectively increase the PMF in Caenorhabditis elegans. Here we show that mtON photoactivation increases the PMF in a dose-dependent manner, supports ATP synthesis, increases resistance to mitochondrial toxins, and modulates energy-sensing behavior. Moreover, transient mtON activation during hypoxic preconditioning prevents the well-characterized adaptive response of hypoxia resistance. Our results show that optogenetic manipulation of the PMF is a powerful tool to modulate metabolism and cell signaling.

Indexed as

MitochondriaOptogeneticsAdenosine TriphosphateAnimalsCaenorhabditis elegansHypoxiaProtonsAdenosine TriphosphateProtonsanoxiahypoxiaischemia reperfusionmetabolismuncoupling

Identifiers

PMID32043300
PMCPMC7132214
OpenAlexW3006421444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.